PROGRESS (Perindopril pROtection aGainst REcurrent Stroke Study) was an international multicentre trial designed primarily to determine the effects of lowering blood pressure on the risk of recurrent strokes, using perindopril alone or with indapamide, in hypertensive and normotensive patients with and without diabetes. Treatment with perindopril ± indapamide for four years reduced the risk of a further stroke by 28% and cerebral haemorrhage by 50%.
Progress Collaborative Group.Randomised trial of perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet2001;358:1033-41.
2.
WHO.World Health Report1999. GenevaWHO . 1999.
3.
Hankey G., Warlow C.Treatment and secondary prevention of stroke: evidence, costs and effects on individuals and populations. Lancet1999 ; 354:1451-63.
4.
Department of Health. Key area handbook.Heart disease and stroke. Health of the Nation series. London: HMSO, 1992.
5.
Blood pressure lowering treatment Trialist's Collaboration.Effects of ACEI, calcium antagonists and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet2000;356:1955-64.
6.
Rodgers A., Neal B., MacMahon S.The effects of blood pressure lowering in cerebrovascular disease . Neurol Rev Int1997;2:12-15.
7.
Bosch J., Yusuf S., Pogue J. et al. Impact of ramipril and vitamin E on cerebrovascular events in the HOPE (Heart Outcomes Prevention Evaluation) trial. J Am Coll Cardiol2000;36:suppl A:324A.
